Overview
Mast cell sarcoma is a rare and aggressive neoplasm characterized by the malignant proliferation of mast cells, often presenting with systemic involvement but occasionally found in isolated, unusual locations such as the brain 1.Diagnosis
Histopathologic confirmation essential using specific stains to identify mast cell immunophenotype and proliferative activity 1.
Imaging studies (e.g., MRI) crucial for localization and extent of disease 1.
Biopsy required for definitive diagnosis and grading based on morphology and mitotic index 1.Management
First-line treatment: Irradiation and intrathecal cytarabine may be considered but showed limited efficacy in the case presented 1.
Adjunctive therapy: Combination chemotherapy demonstrated marked transient tumor regression in intracranial cases 1.
- Specific regimen not detailed, but polychemotherapy approach suggested 1.Special Populations
Pediatrics: An isolated case report in an 8-year-old suggests that pediatric patients may respond to aggressive chemotherapy regimens 1.Key Recommendations
Histopathologic confirmation with specific stains is essential for diagnosing mast cell sarcoma (Evidence: Moderate 1).
Combination chemotherapy should be considered for localized aggressive cases, particularly in unusual locations like the brain, despite transient responses (Evidence: Weak 1).
Irradiation and intrathecal cytarabine may be adjunctive but are not sufficient as standalone treatments (Evidence: Expert opinion 1).References
1 Guenther PP, Huebner A, Sobottka SB, Neumeister V, Weissbach G, Todt H et al.. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. Journal of pediatric hematology/oncology 2001. link